Disc Medicine Stock Market Value
IRON Stock | 54.46 0.93 1.74% |
Symbol | Disc |
Disc Medicine Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Disc Medicine. If investors know Disc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Disc Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Disc Medicine is measured differently than its book value, which is the value of Disc that is recorded on the company's balance sheet. Investors also form their own opinion of Disc Medicine's value that differs from its market value or its book value, called intrinsic value, which is Disc Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Disc Medicine's market value can be influenced by many factors that don't directly affect Disc Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Disc Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Disc Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Disc Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Disc Medicine 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Disc Medicine's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Disc Medicine.
01/28/2025 |
| 02/27/2025 |
If you would invest 0.00 in Disc Medicine on January 28, 2025 and sell it all today you would earn a total of 0.00 from holding Disc Medicine or generate 0.0% return on investment in Disc Medicine over 30 days. Disc Medicine is related to or competes with Anebulo Pharmaceuticals, Adagene, Acrivon Therapeutics,, AnaptysBio, Mineralys Therapeutics,, Olema Pharmaceuticals, and Larimar Therapeutics. Disc Medicine is entity of United States More
Disc Medicine Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Disc Medicine's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Disc Medicine upside and downside potential and time the market with a certain degree of confidence.
Information Ratio | (0.05) | |||
Maximum Drawdown | 10.3 | |||
Value At Risk | (3.34) | |||
Potential Upside | 4.03 |
Disc Medicine Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Disc Medicine's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Disc Medicine's standard deviation. In reality, there are many statistical measures that can use Disc Medicine historical prices to predict the future Disc Medicine's volatility.Risk Adjusted Performance | (0.03) | |||
Jensen Alpha | (0.11) | |||
Total Risk Alpha | (0.10) | |||
Treynor Ratio | (0.12) |
Disc Medicine Backtested Returns
Disc Medicine secures Sharpe Ratio (or Efficiency) of -0.11, which denotes the company had a -0.11 % return per unit of risk over the last 3 months. Disc Medicine exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Disc Medicine's Mean Deviation of 1.79, variance of 4.99, and Standard Deviation of 2.23 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.99, which means possible diversification benefits within a given portfolio. Disc Medicine returns are very sensitive to returns on the market. As the market goes up or down, Disc Medicine is expected to follow. At this point, Disc Medicine has a negative expected return of -0.24%. Please make sure to confirm Disc Medicine's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Disc Medicine performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.43 |
Average predictability
Disc Medicine has average predictability. Overlapping area represents the amount of predictability between Disc Medicine time series from 28th of January 2025 to 12th of February 2025 and 12th of February 2025 to 27th of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Disc Medicine price movement. The serial correlation of 0.43 indicates that just about 43.0% of current Disc Medicine price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.43 | |
Spearman Rank Test | -0.22 | |
Residual Average | 0.0 | |
Price Variance | 0.14 |
Disc Medicine lagged returns against current returns
Autocorrelation, which is Disc Medicine stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Disc Medicine's stock expected returns. We can calculate the autocorrelation of Disc Medicine returns to help us make a trade decision. For example, suppose you find that Disc Medicine has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Disc Medicine regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Disc Medicine stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Disc Medicine stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Disc Medicine stock over time.
Current vs Lagged Prices |
Timeline |
Disc Medicine Lagged Returns
When evaluating Disc Medicine's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Disc Medicine stock have on its future price. Disc Medicine autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Disc Medicine autocorrelation shows the relationship between Disc Medicine stock current value and its past values and can show if there is a momentum factor associated with investing in Disc Medicine.
Regressed Prices |
Timeline |
Pair Trading with Disc Medicine
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Disc Medicine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Disc Medicine will appreciate offsetting losses from the drop in the long position's value.Moving against Disc Stock
0.87 | OPT | Opthea | PairCorr |
0.77 | LTRN | Lantern Pharma | PairCorr |
0.77 | PHGE | Biomx Inc | PairCorr |
0.72 | GANX | Gain Therapeutics | PairCorr |
0.65 | CUE | Cue Biopharma | PairCorr |
The ability to find closely correlated positions to Disc Medicine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Disc Medicine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Disc Medicine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Disc Medicine to buy it.
The correlation of Disc Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Disc Medicine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Disc Medicine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Disc Medicine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Disc Medicine Correlation, Disc Medicine Volatility and Disc Medicine Alpha and Beta module to complement your research on Disc Medicine. To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Disc Medicine technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.